ImKTx1, a new Kv1.3 channel blocker with a unique primary structure

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• Venom toxins from scorpions, snakes, and spiders are crucial for understanding ion channel structure and function.
• Scorpion venoms represent a rich source of diverse peptides with specific ion channel activities.

Purpose of the Study:

• To isolate and characterize a novel toxin peptide from the scorpion Isometrus maculates.
• To investigate the physiological and pharmacological properties of the new toxin, designated ImKTx1.
• To determine the specificity of ImKTx1 against various ion channel subtypes.

Main Methods:

• cDNA library construction for toxin gene isolation from scorpion venom glands.
• Recombinant peptide expression and purification.
• Electrophysiological recordings to assess channel inhibition.
• Multiple sequence alignments for structural comparison.

Main Results:

• A new toxin gene encoding ImKTx1 was isolated from Isometrus maculates venom gland.
• Recombinant ImKTx1, a 39-amino acid peptide with six cysteines, selectively inhibited Kv1.3 channel currents (IC50 = 1.70 µM).
• ImKTx1 showed minimal inhibition of Kv1.1, Kv1.2, Nav1.2, and Nav1.4 channels, indicating high specificity.
• Sequence analysis revealed ImKTx1 lacks homologous toxins but shares cysteine arrangement with Ca(2+) channel toxins.

Conclusions:

• ImKTx1 represents a novel Kv1.3 channel blocker with a unique primary structure.
• This discovery underscores the significant diversity of potassium channel toxins found in scorpion venoms.
• ImKTx1 provides a valuable new molecular template for targeting Kv1.3 channels in research and potential therapeutic applications.